Having problems reading this email? View it in your browser >>
|
||
|
||
Anti-HIV treatmentSide-effects and illnessHIV and hepatitis C virusMany people with HIV are also infected with hepatitis C virus, and the liver disease caused by this virus is an important cause of illness and death in such patients. Treatment for hepatitis C is available, and about two-thirds of people with HIV who receive this treatment soon after they are infected with hepatitis C manage to clear it, as do a third of patients who receive anti-hepatitis C therapy when they’ve had the infection for some time. Researchers have found that the type of anti-HIV treatment a patient receives might affect their response to therapy for hepatitis C. Two studies presented to CROI found that patients who received tenofovir had a better response to anti-hepatitis C treatment. Earlier research found that there might be a reaction between abacavir and ribavirin, a key anti-hepatitis C drug. HIV preventionCriminal HIV transmissionA prosecution for reckless HIV transmission has been dismissed by a judge in Manchester. The judge didn’t think that there was enough evidence for the case to go ahead. The complainant had had unprotected sex with a number of men other than the accused, and had only ever had one HIV test. The defence solicitor had successfully defended two other people accused of reckless HIV transmission. | ||
Connect with us |
||
aidsmap is an award-winning, community-based organisation, which works from the UK. We deliver reliable and accurate HIV information across the world to HIV-positive people and to the professionals who treat, support and care for them.
NAM Publications
Cally Yard, 439 Caledonian Road, London N7 9BG Company limited by guarantee. Registered in England & Wales, number: 2707596 Registered charity, number: 1011220 To unsubscribe please click here Privacy Policy: www.aidsmap.com/about-us/confidentiality |